Table of Contents
Advances in Pharmaceutics
Volume 2014 (2014), Article ID 439158, 9 pages
http://dx.doi.org/10.1155/2014/439158
Research Article

Rejuvenating of Kidney Tissues on Alloxan Induced Diabetic Mice under the Effect of Momordica charantia

1Department of Biochemistry & Bioprocess Technology, Sam Higginbottom Institute of Agriculture, Technology & Sciences, Allahabad, Uttar Pradesh 211008, India
2Department of Molecular & Cellular Engineering, Sam Higginbottom Institute of Agriculture, Technology & Sciences, Allahabad, Uttar Pradesh 211008, India
3PG of Zoology, A.N. College, Patna, Bihar 800013, India
4School of Science, Suresh Gyan Vihar University, Jaipur, Rajasthan 302017, India

Received 2 April 2014; Revised 14 May 2014; Accepted 18 May 2014; Published 15 June 2014

Academic Editor: Hidetaka Akita

Copyright © 2014 Bhaskar Sharma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Orsolic and I. Basic, “Honey bee products and their polyphenolic compounds in treatment of diabetes,” in Phytopharmacology and Therapetutic Values IV, J. N. Govil and V. K. Singh, Eds., vol. 22, pp. 455–471, Stadium Press, 2008. View at Google Scholar
  2. K. K. M. Yue, W.-S. Chung, A. W. N. Leung, and C. H. K. Cheng, “Redox changes precede the occurrence of oxidative stress in eyes and aorta, but not in kidneys of diabetic rats,” Life Sciences, vol. 73, no. 20, pp. 2557–2570, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. I. G. Obrosova, A. G. Minchenko, R. Vasupuram et al., “Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats,” Diabetes, vol. 52, no. 3, pp. 864–871, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Ha, I.-A. Hwang, J. H. Park, and H. B. Lee, “Role of reactive oxygen species in the pathogenesis of diabetic nephropathy,” Diabetes Research and Clinical Practice, vol. 82, no. 1, pp. S42–S45, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. L. M. Ruiz-Muñoz, F. Vidal-Vanaclocha, and I. Lampreabe, “Enalaprilat inhibits hydrogen peroxide production by murine mesangial cells exposed to high glucose concentrations,” Nephrology Dialysis Transplantation, vol. 12, no. 3, pp. 456–464, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. J. V. Hunt, M. A. Bottoms, and M. J. Mitchinson, “Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation: some fundamental differences in proposed mechanisms of glucose oxidation and oxidant production,” Biochemical Journal, vol. 291, no. 2, pp. 529–535, 1993. View at Google Scholar · View at Scopus
  7. M. Anjaneyulu and K. Chopra, “Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney,” American Journal of Nephrology, vol. 24, no. 5, pp. 488–496, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. K. K. M. Yue, S.-N. Leung, P.-M. Man et al., “Alterations in antioxidant enzyme activities in the eyes, aorta and kidneys of diabetic rats relevant to the onset of oxidative stress,” Life Sciences, vol. 77, no. 7, pp. 721–734, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Oršolić, G. Gajski, V. Garaj-Vrhovac, D. Crossed D Signikić, Z. Š. Prskalo, and D. Sirovina, “DNA-protective effects of quercetin or naringenin in alloxan-induced diabetic mice,” European Journal of Pharmacology, vol. 656, no. 1–3, pp. 110–118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. C. Will, F. Vinicor, and E. E. Calle, “Is diabetes mellitus associated with prostate cancer incidence and survival?” Epidemiology, vol. 10, no. 3, pp. 313–318, 1999. View at Google Scholar · View at Scopus
  11. P. Maisonneuve, L. Agodoa, R. Gellert et al., “Cancer in patients on dialysis for end-stage renal disease: an international collaborative study,” The Lancet, vol. 354, no. 9173, pp. 93–99, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Wadood, M. Nisar, A. Rashid, A. Wadood, and A. Khan, “Effect of a compound recipe (medicinal plants) on serum insulin levels of alloxan induced diabetic rabbits,” Journal of Ayub Medical College, Abbottabad, vol. 19, no. 1, pp. 32–38, 2007. View at Google Scholar · View at Scopus
  13. W. D. Winters, Y. S. Huo, and D.-L. Yao, “Inhibition of the progression of type 2 diabetes in the C57BL/6J mouse model by an anti-diabetes herbal formula,” Phytotherapy Research, vol. 17, no. 6, pp. 591–598, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Wadood, A. Wadood, and M. Nisar, “Effect of Ficus relegiosa on blood glucose and total lipid levels of normal and alloxan diabetic rabbits,” Journal of Ayub Medical College, Abbottabad, vol. 15, no. 4, pp. 40–42, 2003. View at Google Scholar · View at Scopus
  15. E. H. Karunanayake and K. H. Tennekoon, “Search of novel hypoglycaemic agents from medicinal plants,” in Diabetes Mellitus and Its Complications-An Update, A. K. Sharma, Ed., pp. 192–196, Macmillan, India, 2003. View at Google Scholar
  16. A. P. Jayasooriya, M. Sakono, C. Yukizaki, M. Kawano, K. Yamamoto, and N. Fukuda, “Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol- enriched diets,” Journal of Ethnopharmacology, vol. 72, no. 1-2, pp. 331–336, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Welihinda, E. H. Karunanayake, M. H. R. Sheriff, and K. S. A. Jayasinghe, “Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes,” Journal of Ethnopharmacology, vol. 17, no. 3, pp. 277–282, 1986. View at Google Scholar · View at Scopus
  18. J. Pitipanapong, S. Chitprasert, M. Goto, W. Jiratchariyakul, M. Sasaki, and A. Shotipruk, “New approach for extraction of charantin from Momordica charantia with pressurized liquid extraction,” Separation and Purification Technology, vol. 52, no. 3, pp. 416–422, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Paul and S. S. Raychaudhuri, “Medicinal uses and molecular identification of two Momordica charantia varieties - a review,” Electronic Journal of Biology, vol. 6, no. 2, pp. 43–51, 2010. View at Google Scholar
  20. H.-L. Cheng, H.-K. Huang, C.-I. Chang, C.-P. Tsai, and C.-H. Chou, “A cell-based screening identifies compounds from the stem of Momordica charantia that overcome insulin resistance and activate AMP-activated protein kinase,” Journal of Agricultural and Food Chemistry, vol. 56, no. 16, pp. 6835–6843, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Lorke, “A new approach to practical acute toxicity testing,” Archives of Toxicology, vol. 54, no. 4, pp. 275–287, 1983. View at Google Scholar · View at Scopus
  22. T. Szkudelski, “The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas,” Physiological Research, vol. 50, no. 6, pp. 537–546, 2001. View at Google Scholar · View at Scopus
  23. S. Lenzen, “The mechanisms of alloxan- and streptozotocin-induced diabetes,” Diabetologia, vol. 51, no. 2, pp. 216–226, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Van Herck, V. Baumans, C. J. W. M. Brandt et al., “Orbital sinus blood sampling in rats as performed by different animal technicians: the influence of technique and expertise,” Laboratory Animals, vol. 32, no. 4, pp. 377–386, 1998. View at Google Scholar · View at Scopus
  25. P. Trinder, “Determination of glucose in blood using glucoseoxidase with an alternative oxygen acceptor,” Annals of Clinical Biochemistry, vol. 6, pp. 24–27, 1969. View at Publisher · View at Google Scholar
  26. J. K. Fawcett and J. E. Scott, “A rapid and precise method for the determination of urea,” Journal of Clinical Pathology, vol. 13, pp. 156–159, 1960. View at Google Scholar · View at Scopus
  27. P. Fossati, L. Prencipe, and G. Berti, “Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine,” Clinical Chemistry, vol. 26, no. 2, pp. 227–231, 1980. View at Google Scholar · View at Scopus
  28. B. T. Doumas, W. Ard Watson, and H. G. Biggs, “Albumin standards and the measurement of serum albumin with bromcresol green,” Clinica Chimica Acta, vol. 31, no. 1, pp. 87–96, 1971. View at Google Scholar · View at Scopus
  29. O. H. Lowry, N. J. Rosehmugh, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  30. R. W. Bonsnes and H. H. Taussky, “On the colorimetric determination of Creatinine by the Jaffe reaction,” The Journal of Biological Chemistry, vol. 158, pp. 581–591, 1945. View at Google Scholar
  31. H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979. View at Google Scholar · View at Scopus
  32. D. E. Kleiner, E. M. Brunt, M. Van Natta et al., “Design and validation of a histological scoring system for nonalcoholic fatty liver disease,” Hepatology, vol. 41, no. 6, pp. 1313–1321, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. S. S. Katewa, B. L. Chaudhary, and A. Jain, “Folk herbal medicines from tribal area of Rajasthan, India,” Journal of Ethnopharmacology, vol. 92, no. 1, pp. 41–46, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Rajagopal and K. Sasikala, “Antihyperglycaemic and antihyperlipidaemic effects of Nymphaea stellata in alloxan-induced diabetic rats,” Singapore Medical Journal, vol. 49, no. 2, pp. 137–141, 2008. View at Google Scholar · View at Scopus
  35. D. A. Allen, S. Harwood, M. Varagunam, M. J. Raftery, and M. M. Yaqoob, “High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases,” The FASEB Journal, vol. 17, no. 8, pp. 908–910, 2003. View at Google Scholar · View at Scopus
  36. S. S. Chung, E. C. Ho, K. S. Lam, and S. K. Chung, “Contribution of poloyl pathway to diabetes-induced oxidative stress,” Journal of the American Society of Nephrology, vol. 14, no. 8, pp. 233–236, 2003. View at Google Scholar
  37. M. M. Dallak, P. D. Mikhailidis, A. M. Haidara et al., “Oxidative stress as a common mediator for apoptosis induced-cardiac damage in diabetic rats,” The Open Cardiovascular Medicine Journal, vol. 2, pp. 70–78, 2008. View at Google Scholar
  38. N. P. C. Fernandes, C. V. Lagishetty, V. S. Panda, and S. R. Naik, “An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract,” BMC Complementary and Alternative Medicine, vol. 7, article 29, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. X.-Q. Yuan, X.-H. Gu, J. Tang, and J. Wasswa, “Hypoglycemic effect of semipurified peptides from Momordica charantia L. var. Abbreviata Ser. in alloxan-induced diabetic mice,” Journal of Food Biochemistry, vol. 32, no. 1, pp. 107–121, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Chaturvedi, S. George, M. Milinganyo, and Y. B. Tripathi, “Effect of Momordica charantia on lipid profile and oral glucose tolerance in diabetic rats,” Phytotherapy Research, vol. 18, no. 11, pp. 954–956, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Luzi, M. A. Rafi, T. Victoria, G. B. Baskin, and D. A. Wenger, “Characterization of the rhesus monkey galactocerebrosidase (GALC) cDNA and gene and identification of the mutation causing globoid cell leukodystrophy (Krabbe disease) in this primate,” Genomics, vol. 42, no. 2, pp. 319–324, 1997. View at Publisher · View at Google Scholar · View at Scopus
  42. B. A. Salau, O. Osilesi, G. O. Idowu, S. Musa, and E. O. Ajani, “Effects of fruits and vegetables on cardiovascular disease risk factors in non-insulin dependent diabetes mellitus (NIDDM) subjects,” African Journal of Medical and Pharmaceutical Sciences, vol. 7, pp. 21–26, 2003. View at Google Scholar
  43. A. M. L. Dans, M. V. C. Villarruz, C. A. Jimeno et al., “The effect of Momordica charantia capsule preparation on glycemic control in Type 2 Diabetes Mellitus needs further studies,” Journal of Clinical Epidemiology, vol. 60, no. 6, pp. 554–559, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Eidi, M. Eidi, and M. Sokhteh, “Effect of fenugreek (Trigonella foenum-graecum L.) seeds on serum parameters in normal and streptozotocin-induced diabetic rats,” Nutrition Research, vol. 27, no. 11, pp. 728–733, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. S. K. Rashmi and D. Kumar, “Antidiabetic effect of Euphorbia hirta leaves in alloxan induced diabetic mice,” Pharmacologyonline, vol. 1, pp. 61–69, 2010. View at Google Scholar · View at Scopus
  46. S. Ahmed, M. A. Awal, M. M. Rahman, and M. Mostofa, “Comparative efficacy of neem and karela with insulin and glibenclamide on biochemical parameters in rabbit,” Journal of Animal and Veterinary Advances, vol. 4, no. 2, pp. 221–223, 2005. View at Google Scholar
  47. P. D. Mayne, “Lipid metabolism,” in Clinical Chemistry in Diagnosis and Treatment, pp. 240–243, Clays publisher, London, UK, 6th edition, 1993. View at Google Scholar
  48. J. Virdi, S. Sivakami, S. Shahani, A. C. Suthar, M. M. Banavalikar, and M. K. Biyani, “Antihyperglycemic effects of three extracts from Momordica charantia,” Journal of Ethnopharmacology, vol. 88, no. 1, pp. 107–111, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Aloulou, K. Hamden, D. Elloumi et al., “Hypoglycemic and antilipidemic properties of kombucha tea in alloxan-induced diabetic rats,” BMC Complementary and Alternative Medicine, vol. 12, article 63, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. N. Hfaiedh, J .C. Murat, and A. Elfeki, “Diabetes-induced damages in rat kidney and brain and protective effects of natural antioxidants,” Journal of Nutrition & Food Sciences, vol. 3, no. 4, 2013. View at Publisher · View at Google Scholar
  51. M. G. Moghaddam, I. Ansari, M. Roghani, and M. Moradi, “The Effects of Origanum Majorana on oxidative stress and histopathology of renal tissue among streptozotocin-induced diabetic rat,” Thrita Journal of Medical Sciences, vol. 2, no. 1, pp. 29–34, 2013. View at Publisher · View at Google Scholar
  52. A. C. Guyton and J. E. Hall, Textbook of Medical Physiology, WB Saundersp, Philadelphia, Pa, USA, 10th edition, 2000.
  53. G. L. Bakris, “Diabetic nephropathy: What you need to know to preserve kidney function,” Postgraduate Medicine, vol. 93, no. 5, pp. 89–93, 1993. View at Google Scholar · View at Scopus
  54. T. Tuvemo, U. Ewald, M. Kobbah, and L. A. Proos, “Serum magnesium and protein concentrations during the first five years of insulin-dependent diabetes in children,” Acta Paediatrica, International Journal of Paediatrics, Supplement, vol. 86, no. 418, pp. 7–10, 1997. View at Google Scholar · View at Scopus
  55. N. Makare, S. Bodhankar, and V. Rangari, “Immunomodulatory activity of alcoholic extract of Mangifera indica L. in mice,” Journal of Ethnopharmacology, vol. 78, no. 2-3, pp. 133–137, 2001. View at Publisher · View at Google Scholar · View at Scopus
  56. T. P. Almdal and H. Vilstrup, “Strict insulin therapy normalises organ nitrogen contents and the capacity of urea nitrogen synthesis in experimental diabetes in rats,” Diabetologia, vol. 31, no. 2, pp. 114–122, 1988. View at Google Scholar · View at Scopus
  57. A. Bener, M. Zirie, and A. Al-Rikabi, “Genetics, obesity, and environmental risk factors associated with type 2 diabetes,” Croatian Medical Journal, vol. 46, no. 2, pp. 302–307, 2005. View at Google Scholar · View at Scopus
  58. J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky, “Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes,” Endocrine Reviews, vol. 23, no. 5, pp. 599–622, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Rahimi, S. Nikfar, B. Larijani, and M. Abdollahi, “A review on the role of antioxidants in the management of diabetes and its complications,” Biomedicine and Pharmacotherapy, vol. 59, no. 7, pp. 365–373, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. Y. Soon and B. K. H. Tan, “Evaluation of the hypoglycemic and anti-oxidant activities of Morinda officinalis in streptozotocin-induced diabetic rats,” Singapore Medical Journal, vol. 43, no. 2, pp. 77–85, 2002. View at Google Scholar · View at Scopus
  61. D. Sathishsekar and S. Subramanian, “Antioxidant properties of Momordica Charantia (bitter gourd) seeds on Streptozotocin induced diabetic rats,” Asia Pacific Journal of Clinical Nutrition, vol. 14, no. 2, pp. 153–158, 2005. View at Google Scholar · View at Scopus
  62. X.-F. Zhang and B. K.-H. Tan, “Antihyperglycaemic and anti-oxidant properties of Andrographis paniculata in normal and diabetic rats,” Clinical and Experimental Pharmacology and Physiology, vol. 27, no. 5-6, pp. 358–363, 2000. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Kalaivani, A. Umamaheswari, A. Vinayagam, and K. Kalaivani, “Anti-hyperglycemic and antioxidant properties of Cassia auriculata leaves and flowers on alloxan induced diabetic rats,” Pharmacologyonline, vol. 1, pp. 204–217, 2008. View at Google Scholar · View at Scopus